Literature DB >> 24025661

Valuing SF-6D Health States Using a Discrete Choice Experiment.

Richard Norman1, Rosalie Viney1, John Brazier2, Leonie Burgess3, Paula Cronin1, Madeleine King4, Julie Ratcliffe5, Deborah Street3.   

Abstract

BACKGROUND: SF-6D utility weights are conventionally produced using a standard gamble (SG). SG-derived weights consistently demonstrate a floor effect not observed with other elicitation techniques. Recent advances in discrete choice methods have allowed estimation of utility weights. The objective was to produce Australian utility weights for the SF-6D and to explore the application of discrete choice experiment (DCE) methods in this context. We hypothesized that weights derived using this method would reflect the largely monotonic construction of the SF-6D.
METHODS: We designed an online DCE and administered it to an Australia-representative online panel (n = 1017). A range of specifications investigating nonlinear preferences with respect to additional life expectancy were estimated using a random-effects probit model. The preferred model was then used to estimate a preference index such that full health and death were valued at 1 and 0, respectively, to provide an algorithm for Australian cost-utility analyses.
RESULTS: Physical functioning, pain, mental health, and vitality were the largest drivers of utility weights. Combining levels to remove illogical orderings did not lead to a poorer model fit. Relative to international SG-derived weights, the range of utility weights was larger with 5% of health states valued below zero.
CONCLUSION: s. DCEs can be used to investigate preferences for health profiles and to estimate utility weights for multi-attribute utility instruments. Australian cost-utility analyses can now use domestic SF-6D weights. The comparability of DCE results to those using other elicitation methods for estimating utility weights for quality-adjusted life-year calculations should be further investigated.
© The Author(s) 2013.

Entities:  

Keywords:  Australia; SF-6D; cost-utility analysis; discrete choice experiment; economic evaluation; quality of life valuation

Mesh:

Year:  2013        PMID: 24025661     DOI: 10.1177/0272989X13503499

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  33 in total

1.  The impact of progressive chronic kidney disease on health-related quality-of-life: a 12-year community cohort study.

Authors:  Melanie L R Wyld; Rachael L Morton; Phil Clayton; Muh Geot Wong; Meg Jardine; Kevan Polkinghorne; Steve Chadban
Journal:  Qual Life Res       Date:  2019-04-01       Impact factor: 4.147

2.  The relationship between SF-6D utility scores and lifestyle factors across three life stages: evidence from the Australian Longitudinal Study on Women's Health.

Authors:  Jeeva Kanesarajah; Michael Waller; Jennifer A Whitty; Gita D Mishra
Journal:  Qual Life Res       Date:  2017-02-03       Impact factor: 4.147

3.  Estimates of health utility scores in chronic kidney disease.

Authors:  Nigar Sekercioglu; Bryan Curtis; Sean Murphy; Gord Blackhouse; Brendan Barrett
Journal:  Int Urol Nephrol       Date:  2017-07-21       Impact factor: 2.370

4.  Does Device or Connection Type Affect Health Preferences in Online Surveys?

Authors:  John D Hartman; Benjamin M Craig
Journal:  Patient       Date:  2019-12       Impact factor: 3.883

5.  Health-Related Quality of Life Associated with Barrett's Esophagus and Cancer.

Authors:  Norma B Bulamu; Gang Chen; Julie Ratcliffe; Ann Schloite; Tim Bright; David I Watson
Journal:  World J Surg       Date:  2019-06       Impact factor: 3.352

6.  Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?

Authors:  Brendan Mulhern; Richard Norman; Paula Lorgelly; Emily Lancsar; Julie Ratcliffe; John Brazier; Rosalie Viney
Journal:  Pharmacoeconomics       Date:  2017-04       Impact factor: 4.981

7.  SF-6D Portuguese population norms.

Authors:  Pedro L Ferreira; Lara N Ferreira; Luis N Pereira
Journal:  Eur J Health Econ       Date:  2014-02-07

8.  The societal monetary value of a QALY associated with EQ-5D-3L health gains.

Authors:  Laura Vallejo-Torres; Borja García-Lorenzo; Oliver Rivero-Arias; José Luis Pinto-Prades
Journal:  Eur J Health Econ       Date:  2019-11-28

9.  QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.

Authors:  M T King; D S J Costa; N K Aaronson; J E Brazier; D F Cella; P M Fayers; P Grimison; M Janda; G Kemmler; R Norman; A S Pickard; D Rowen; G Velikova; T A Young; R Viney
Journal:  Qual Life Res       Date:  2016-01-20       Impact factor: 4.147

10.  The Impact of Different DCE-Based Approaches When Anchoring Utility Scores.

Authors:  Richard Norman; Brendan Mulhern; Rosalie Viney
Journal:  Pharmacoeconomics       Date:  2016-08       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.